Back to dashboard
MedicaidCoverageMedium impact

Newsletter Vol. 15, No. 13

New Jersey Medicaid·NJ · Nephrology, Oncology, Hematology·Provider Notice
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

This is a provider notice regarding Epoetin Alfa (Erythropoietin/EPO), a medication used to treat anemia. Without access to the full policy content, the specific changes to coverage, billing, or prior authorization requirements cannot be determined from the summary alone.

Action Required

Action needed
Immediately: Billing team must download and review the full policy document at https://www.njmmis.com/documentDownload.aspx?document=15-13.pdf to understand specific changes to Epoetin Alfa billing, coverage, or prior authorization requirements. Update billing procedures accordingly based on the detailed policy content.

Related policy hubs